Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-134640)

Filing Details

Accession Number:: 0001209191-16-134640
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-08-01 17:04:51
Reporting Period:: 2016-07-28

Filing Date:: 2016-08-01
Accepted Time:: 2016-08-01 17:04:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
816284	Celgene Corp	CELG	Pharmaceutical Preparations (2834)	222711928

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1232505	J Robert Hugin	C/O Celgene Corporation 86 Morris Avenue Summit NJ 07901	See Remarks	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-07-28	100,000	$110.00	1,022,201	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2016-08-01	29,669	$0.00	29,669	$114.69

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
29,669		2026-08-01	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	490	Indirect	401(k) Plan
Common Stock	9,600	Indirect	Children

Footnotes

These shares were sold by the reporting person pursuant to a Rule 10b5-1 plan.
Option is immediately exercisable and will vest in four equal annual installments commencing on August 1, 2017.
The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as Amended and Restated as of June 15, 2015).